| Trial ID: | L2277 |
| Source ID: | NCT01354925
|
| Associated Drug: |
Insulin Treatment During Ramadan
|
| Title: |
Management of Type-2 Diabetic Patients Treated With Insulin During the Ramadan
|
| Acronym: |
DMR
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Type 2|Treatment During Ramadan
|
| Interventions: |
DRUG: Insulin treatment during Ramadan|DRUG: Standard of care
|
| Outcome Measures: |
Primary: Difference in mean 4-point SMBG during days 23-30 of treatment between the two groups., days 23-30 of treatment |
|
| Sponsor/Collaborators: |
Sponsor: Meir Medical Center
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
245
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2011-09
|
| Completion Date: |
2011-10
|
| Results First Posted: |
|
| Last Update Posted: |
2013-04-12
|
| Locations: |
Clalit HMO, Haifa, Israel
|
| URL: |
https://clinicaltrials.gov/show/NCT01354925
|
